bond of the hydrogen to be abstracted are linear or nearly
linear, we concluded that the 1,6-HT reaction with a PRT
group would likely take place. Thus, we chose the 2-bro-
mobenzylidene group as a novel PRT group, thinking that it
would be useful in protecting 1,2- or 1,3-diols similar to other
benzylidene groups and the reactive aryl radical generated
from it could abstract a hydrogen on an aliphatic carbon.
We anticipated that the regio- as well as stereoselective 1,6-
hydrogen abstraction might occur with the 2-bromoben-
zylidene PRT group, because the bromophenyl moiety
seemed to be conformationally constrained as a result of the
rigid 1,3-dioxo ring formed from a diol and 2-bromoben-
zaldehyde or its equivalent.
as precursors for 4′-branched nucleosides having considerable
biological importance,5,6 would be synthesized via radical
C-C bond formation at the 4-position.
Thus, 1-O-(3-fluorobenzoyl)-2,3-O-endo-2-bromoben-
zylidene-5-O-tert-butyl-diphenylsilyl (TBDPS)-R-D-ribose
(4) was synthesized as the substrate for examining the 1,6-
HT reaction (Scheme 3). Treatment of D-ribose with 2-Br-
Scheme 3
We decided to examine the potential of 2-bromoben-
zylidene group as a PRT group using ribose derivatives as
reaction substrates. Thus, 2,3-O-endo-benzylidene-R-D-ribose
derivative I was designed as a model substrate (Scheme 2).
Scheme 2
PhCH(OEt)2 and p-TsOH in DMF at room temperature gave
the desired endo-benzylidene product 2. After selective
protection of the 5-hydroxyl of 2 with a TBDPS group,
Mitsunobu reaction of the product 3 with a Ph3P/diisopropyl
azodicarboxylate (DIAD)/3-F-PhCO2H system in CH2Cl2
gave highly stereoselectively the R-riboside 4,7 the substrate
for the radical reaction. Deuterium-labeling experiments of
Scheme 4
Treatment of the substrate I under reductive radical reaction
conditions, such as a Bu3SnH/AIBN system, would generate
the aryl radical II. The 1,5-HT, i.e., abstraction of a hydrogen
at the 2- or 3-position of the ribose by the aryl radical, would
be impossible as a result of the steric demand of the endo-
benzylidene structure. Thus, we expected that, because of
the rigid ring system, the desired 1,6-HT might selectively
occur to generate the ribose 4-radical III. If, by this method,
the ribose 4-radical III could be effectively generated,
4-branched ribose derivatives, which are useful, for example,
4 with Bu3SnD were first investigated with the idea of
clarifying whether the desired 1,6-HT reaction had indeed
(3) For examples of HT reactions, see: (a) Curran, D. P.; Kim, D.; Liu,
H. T.; Shen, W. J. Am. Chem. Soc. 1988, 110, 5900-5902. (b) Lathbury,
D. C.; Parsons, P. J.; Pinto, I. J. Chem. Soc., Chem. Commun. 1988, 81-
82. (c) Wiedenfeld, D.; Breslow, R. J. Am. Chem. Soc. 1991, 113, 8977-
8978. (d) Brown, C. D. S.; Simpkins, N. S.; Clinch, K. Tetrahedron Lett.
1993, 34, 131-132. (e) Bosch, E.; Bachi, M. D. J. Org. Chem. 1993, 58,
5581-5582. (f) Robertson, J.; Peplow, M. A.; Pillai, J. Tetrahedron Lett.
1996, 37, 5825-5828. (g) Bertrand, M. P.; Crich, D.; Nouguier, R.; Samy,
R.; Stien, D. J. Org. Chem. 1996, 61, 3588-3589. (h) Kittaka, A.; Asakura,
T.; Kuze, T.; Tanaka, H.; Yamada, N.; Nakamura, K.; Miyasaka, T. J. Org.
Chem. 1999, 64, 7081-7093. (i) Chatgilialoglu, C.; Gimisis, T.; Spada, G.
P. Chem. Eur. J. 1999, 5, 2866-2876. (j) Robertson, J.; Pillai, J.; Lush, R.
K. Chem. Soc. ReV. 2001, 30, 94-103 and references therein.
(5) (a) Giese, B.; Erdmann, P.; Schafer, T.; Schwitter, U. Synthesis 1994,
1310-3112. (b) Hayakawa, H.; Kohgo, S.; Kitano, K.; Ashida, N.; Kodama,
E.; Mitsuya, H.; Ohrui, H. AntiViral Chem. Chemother. 2004, 15, 169-
187 and references therein.
(6) (a) Shuto, S.; Kanazaki, M.; Ichikawa, S.; Matsuda, A. J. Org. Chem.
1997, 62, 5676-5677. (b) Shuto, S.; Kanazaki, M.; Ichikawa, S.; Minakawa,
N.; Matsuda, A. J. Org. Chem. 1998, 63, 746-754. (c) Ueno, Y.; Nagasawa,
Y.; Sugimoto, I.; Kojima, N.; Kanazaki, M.; Shuto, S.; Matsuda, A. J. Org.
Chem. 1998, 63, 1660-1667. (d) Sugimoto, I.; Shuto, S.; Mori, S.; Shigeta,
S.; Matsuda, A. Bioorg. Med. Chem. Lett. 1999, 9, 385-388. (e) Kanazaki,
M.; Ueno, Y.; Shuto, S.; Matsuda, A. J. Am. Chem. Soc. 2000, 122, 2422-
2432. (f) Yamamoto, Y.; Shuto, S.; Tamura, Y.; Kodama, T.; Hoshika, S.;
Ichikawa, S.; Ueno, Y.; Ohtsuka, E.; Komatsu, Y.; Matsuda, A. Biochemistry
2004, 43, 8690-8699 and references therein.
(4) (a) Bosch, E.; Bachi, M. D. J. Org. Chem. 1993, 58, 5581-5582.
(b) Baldwin, J. E.; Adlington, R. M.; Robertson, J. Tetrahedron 1991, 47,
6795-6812.
3292
Org. Lett., Vol. 8, No. 15, 2006